Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation
|
October 13, 2009
Report of a pilot, double-blind, placebo-controlled study of megestrol acetate in elderly dialysis patients with cachexia
Shing-Shing Yeh, Mozhdeh Marandi, Henry C Thode, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 26, 2006
A study of a reduced-intensity conditioning regimen followed by allogeneic stem cell transplantation for patients with hematologic malignancies using Campath-1H as part of a graft-versus-host disease strategy
Tsiporah Shore, John Harpel, Michael W Schuster, et al.
Journal of Adolescent and Young Adult Oncology
|
November 30, 2018
Illness Uncertainties Tied to Developmental Tasks Among Young Adult Survivors of Hematologic Cancers
Aliza A Panjwani, Amanda Mía Marín-Chollom, Ian Z Pervil, et al.
Experimental Hematology
|
September 13, 2002
The effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet recovery in breast cancer patients undergoing autologous bone marrow transplantation
Michael W Schuster, Roy Beveridge, Debra Frei-Lahr, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 22, 2007
Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant
Michael W Schuster, Tsiporah B Shore, John G Harpel, et al.
Annals of Hematology
|
February 4, 2026
Burixafor, a CXCR4 inhibitor with a differentiated kinetics profile: results of a phase 2 study for rapid cell mobilization in multiple myeloma and lymphoma patients undergoing transplant
Devki D Sukhtankar, Pina M Cardarelli, Bita Jalilizeinali, et al.
British Journal of Haematology
|
September 4, 2009
Impact of prior therapies on the relative efficacy of bortezomib compared with dexamethasone in patients with relapsed/refractory multiple myeloma
Dan T Vogl, Edward A Stadtmauer, Paul G Richardson, et al.
British Journal of Haematology
|
November 7, 2008
Bortezomib is associated with better health-related quality of life than high-dose dexamethasone in patients with relapsed multiple myeloma: results from the APEX study
Stephanie J Lee, Paul G Richardson, Pieter Sonneveld, et al.
American Journal of Hematology
|
April 4, 2017
A phase 1 study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients with acute myeloid leukemia
Hagop M Kantarjian, Michael W Schuster, Nitin Jain, et al.
British Journal of Haematology
|
August 21, 2008
Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myeloma
Sagar Lonial, Paul G Richardson, Jesús San Miguel, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation
|
October 13, 2009
Report of a pilot, double-blind, placebo-controlled study of megestrol acetate in elderly dialysis patients with cachexia
Shing-Shing Yeh, Mozhdeh Marandi, Henry C Thode, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 26, 2006
A study of a reduced-intensity conditioning regimen followed by allogeneic stem cell transplantation for patients with hematologic malignancies using Campath-1H as part of a graft-versus-host disease strategy
Tsiporah Shore, John Harpel, Michael W Schuster, et al.
Journal of Adolescent and Young Adult Oncology
|
November 30, 2018
Illness Uncertainties Tied to Developmental Tasks Among Young Adult Survivors of Hematologic Cancers
Aliza A Panjwani, Amanda Mía Marín-Chollom, Ian Z Pervil, et al.
Experimental Hematology
|
September 13, 2002
The effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet recovery in breast cancer patients undergoing autologous bone marrow transplantation
Michael W Schuster, Roy Beveridge, Debra Frei-Lahr, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 22, 2007
Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant
Michael W Schuster, Tsiporah B Shore, John G Harpel, et al.
Annals of Hematology
|
February 4, 2026
Burixafor, a CXCR4 inhibitor with a differentiated kinetics profile: results of a phase 2 study for rapid cell mobilization in multiple myeloma and lymphoma patients undergoing transplant
Devki D Sukhtankar, Pina M Cardarelli, Bita Jalilizeinali, et al.
British Journal of Haematology
|
September 4, 2009
Impact of prior therapies on the relative efficacy of bortezomib compared with dexamethasone in patients with relapsed/refractory multiple myeloma
Dan T Vogl, Edward A Stadtmauer, Paul G Richardson, et al.
British Journal of Haematology
|
November 7, 2008
Bortezomib is associated with better health-related quality of life than high-dose dexamethasone in patients with relapsed multiple myeloma: results from the APEX study
Stephanie J Lee, Paul G Richardson, Pieter Sonneveld, et al.
American Journal of Hematology
|
April 4, 2017
A phase 1 study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients with acute myeloid leukemia
Hagop M Kantarjian, Michael W Schuster, Nitin Jain, et al.
British Journal of Haematology
|
August 21, 2008
Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myeloma
Sagar Lonial, Paul G Richardson, Jesús San Miguel, et al.
Page
of 4